Advanced search×

Improved outcomes in the management of esophageal cancer with the addition of surgical resection to chemoradiation therapy.

Shaun McKenzie, Brian Mailey, Avo Artinyan, Michelle Metchikian, Stephen Shibata, Kemp Kernstine, and Joseph Kim

Ann Surg Oncol 18(2):551-8 (2011) PMID 20839062

For patients with locally advanced esophageal cancer, prospective randomized clinical trials have reported no added value of surgical resection to chemoradiation alone. Using a large regional cancer registry, our objective was to determine whether curative-intent esophageal resection provided a survival advantage in the multimodality management of esophageal cancer.

DOI: 10.1245/s10434-010-1314-7
Version: za2963e q8zaa q8zbd q8zcb q8zd2 q8ze0 q8zfb q8zge
Buy PDF

Similar articles you may find interesting…

  1. The study design and rationale of the randomized controlled trial: translating COPD guidelines into primary care practice.
    Donna R Parker, Charles B Eaton, and Joseph Wroblewski

    BMC Fam Pract 14(1):56 (2013) PMID 23641803

    We will also examine the use of a patient activation tool - 'MyLungAge' - to prompt patients at risk for or who have COPD to request spirometry confirmation and to request support for smoking cessation if a smoker. DISCUSSION: Using a multi-modal intervention of patient activation and a technology-s...
    PDF not found
  2. Discussing Uncertainty and Risk in Primary Care: Recommendations of a Multi-Disciplinary Panel Regarding Communication Around Prostate Cance...
    Michael Wilkes, Malathi Srinivasan, and Marcus Plescia

    J Gen Intern Med (2013) PMID 23649782

    Conference outcomes present an expert consensus of strategies likely to improve value-concordant prostate cancer screening decisions. In addition, the methodology used to obtain agreement provides a model of successful collaboration around this and future controversial cancer screening issues, which...
    Buy PDF
  3. The Role of Radiation in Retroperitoneal Sarcomas.
    Pranshu Mohindra, Heather B Neuman, and Kevin R Kozak

    Curr Treat Options Oncol (2013) PMID 23649911

    We believe that postoperative radiotherapy should be reserved for very high-risk cases and should be treated to a dose of ≥60 Gy respecting normal tissue dose tolerances. An additional approach that we consider in the postoperative setting is close surveillance with consideration of preoperative...
    Buy PDF